• Accueil >
  • Publications >
  • Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis

Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis

1 janv. 2017Breast Cancer Research and Treatment

DOI : 10.1007/s10549-016-4040-4

Auteurs

Clémentine Jankowski, S. Guiu, M. Cortet, C. Charon-Barra, I. Desmoulins, V. Lorgis, L. Arnould, P. Fumoleau, B. Coudert, R. Rouzier, C. Coutant, F. Reyal